Related content

(-)-Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions

By Jin G.-Z.   Zhu Z.-T.   Fu Y.  

Trends in Pharmacological Sciences, Vol. 23, Iss. 1, 2002-01 ,pp. : 4-7

Elsevier

Access to resources Recommend Favorite

F15063, a potential antipsychotic with dopamine D₂/D₃ antagonist, 5-HT_1A agonist and D₄ partial agonist properties: (IV) duration of brain D2-like receptor occupancy and antipsychotic-like activity versus plasma concentration in mice

By Assié Marie-Bernadette   Bardin Laurent   Auclair Agnès   Consul-Denjean Nathalie   Sautel François   Depoortère Ronan   Newman-Tancredi Adrian  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 4, 2007-06 ,pp. : 241-250

Springer Publishing Company

Access to resources Recommend Favorite

The dopamine D₁ receptor agonist and D₂ receptor antagonist LEK-8829 attenuates reinstatement of cocaine-seeking in rats

By Milivojevič Nataša   Krisch Igor   Sket Dušan   Živin Marko  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 369, Iss. 6, 2004-06 ,pp. : 576-582

Springer Publishing Company

Access to resources Recommend Favorite

Aripiprazole: a partial dopamine D2 receptor agonist antipsychotic

By Keck Jr Paul E   McElroy Susan L  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 4, 2003-04 ,pp. : 655-662

Informa Healthcare

Access to resources Recommend Favorite

D 1 Agonist and/or D 2 antagonist dopamine receptor properties of a series of ergoline derivatives: a structure-activity study

By Mantegani S.   Arlandini E.   Bandiera T.   Borghi D.   Brambilla E.   Caccia C.   Cervini M.A.   Cremonesi P.   McArthur R.A.   Traquandi G.   Varasi M.  

European Journal of Medicinal Chemistry, Vol. 34, Iss. 2, 1999-02 ,pp. : 107-124

Elsevier

Access to resources Recommend Favorite